Verona Pharma plc
VRNADelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001657312
Verona Pharma plc was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 243 institutions reported holding it in 13F filings for Q3 2025, worth $8.57B in total; superinvestors Duquesne Family Office and Soros Fund Management held it.
13F holders, Q1 2024
Institutional positions in Verona Pharma plc as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 113
- −4 vs. Q4 2023
- Shares held
- 67.0M
- −608.7K (−0.9%) vs. Q4 2023
- Total value
- $1.08B
- −$260.7M (−19.4%) vs. Q4 2023
- New holders
- 15
- 44 more added
- Sold out
- 19
- 28 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $359.0K |
| Q3 2025 | 243 | $8.57B |
| Q2 2025 | 292 | $7.18B |
| Q1 2025 | 258 | $4.58B |
| Q4 2024 | 191 | $3.19B |
| Q3 2024 | 150 | $1.95B |
| Q2 2024 | 125 | $957.0M |
| Q1 2024 | 113 | $1.08B |
| Q4 2023 | 117 | $1.35B |
| Q3 2023 | 102 | $1.07B |
| Q2 2023 | 105 | $1.33B |
| Q1 2023 | 95 | $1.21B |
| Q4 2022 | 88 | $1.31B |
| Q3 2022 | 68 | $529.0M |
| Q2 2022 | 40 | $145.9M |
| Q1 2022 | 39 | $181.7M |
| Q4 2021 | 42 | $248.0M |
| Q3 2021 | 40 | $202.7M |
| Q2 2021 | 37 | $239.9M |
| Q1 2021 | 37 | $305.1M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Verona Pharma plc; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Janus Henderson Group PLC | 2,031,994 | $32.7M | 0.02% | +228,633+12.7% | Added |
| Eventide Asset Management, LLC | 2,187,520 | $35.2M | 0.55% | +809,739+58.8% | Added |
| Federated Hermes, Inc. | 2,258,600 | $36.3M | 0.08% | −234,930−9.4% | Reduced |
| Octagon Capital Advisors LP | 2,369,000 | $38.1M | 4.63% | 00.0% | Unchanged |
| Carlyle Group Inc. | 2,457,500 | $39.4M | 2.49% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 3,014,349 | $48.5M | 2.05% | 00.0% | Unchanged |
| Deep Track Capital, LP | 3,187,415 | $51.3M | 1.47% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 3,398,067 | $54.7M | 1.07% | −379,711−10.1% | Reduced |
| Vivo Capital, LLC | 3,610,177 | $58.1M | 4.56% | −639,741−15.1% | Reduced |
| Perceptive Advisors LLC | 3,761,576 | $60.5M | 1.07% | −104,638−2.7% | Reduced |
| Wellington Management Group LLP | 3,909,466 | $62.9M | 0.01% | +125,472+3.3% | Added |
| NEA Management Company, LLC | 5,108,563 | $89.9M | 5.58% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 6,317,990 | $101.7M | 1.29% | 00.0% | Unchanged |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −780,900−100.0% | Sold out |
| Tri Locum Partners LP | 0 | $0 | 0.00% | −293,112−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −251,106−100.0% | Sold out |
| Nicholas Investment Partners, LP | 0 | $0 | 0.00% | −169,126−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −71,533−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −50,836−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −40,215−100.0% | Sold out |
| D.A. Davidson & Co. | 0 | $0 | 0.00% | −33,400−100.0% | Sold out |
| Ghost Tree Capital, LLC | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −29,669−100.0% | Sold out |
| Legato Capital Management LLC | 0 | $0 | 0.00% | −24,329−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −19,000−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −18,065−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −17,819−100.0% | Sold out |
| Parkwood LLC | 0 | $0 | 0.00% | −13,953−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −11,343−100.0% | Sold out |
| Cape Investment Advisory, Inc. | 0 | $0 | 0.00% | −2,001−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −295−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |